Article

Impact of Genes and Lifestyle on LDL in Young Women

Results of a new study of causes of elevated LDL in young women supports greater focus on early assessment and intervention in this population.

Please click here for first slide.

 

 

Young Women with High LDL: A Neglected Population? CV issues are underdiagnosed, undertreated, and understudied in women despite the fact that CVD is the leading cause of death in women. Are there specific genetic and lifestyle factors that affect LDL in younger women?

 

NEXT

 

Dutch Study of Genes, Lifestyle, and LDL  in Younger Women. Evaluated genetic predisposition and lifestyle factors in women with an average age of 33 years.

NEXT

 

High LDL Linked to Poor Lifestlye. Low LDL scores linked with genetic predisposition for hypocholesterolemia but not with unhealthy lifestyle. High LDL scores also reflected genetic tendancy but more than half of subjects with very high LDL had unhealthy lifestyle scores.

NEXT

 

Clinical Implications. Young women may be overlooked for CV risk assessment; may be genetically predisposed to elevated LDL or be prone to dietary indescretion. Age- and sex-based LDL cutoffs rather than fixed LDL levels may better identify patients who need genetic testing for familial hypercholesterolemia.

NEXT

 

Take Home Points

  • Subanalysis of a Dutch cohort study found that 17% of young women with genes for hypercholesterolemia were undiagnosed and untreated.

  • The majority of young women with very high LDL had unhealthy lifestyles.

  • Young women who appear healthy may still need early assessment and intervention to decrease CV risk.
Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
Marianna Fontana, MD, PhD: Declines in Kidney Function Frequent in ATTR-CM  | Image Credit: Radcliffe Cardiology
© 2024 MJH Life Sciences

All rights reserved.